Остеопороз, саркопения и старение — тройная сочетанная патология в гериатрии (обзор литературы)

Взаимодействие между костной и мышечной тканями выходит за рамки простых механических взаимосвязей. Функция скелетных мышц не ограничивается локомоцией тела в пространстве, поддержанием равновесия и осанки, мышечная ткань является метаболически активной. Костная ткань, в свою очередь, обладает эндокринной функцией и вырабатывает активные метаболиты и гормоны, которые оказывают влияние на скелетную мускулатуру, инсулинорезистентность, жировую ткань и метаболизм в целом. На фоне старения возрастает риск развития остеопороза и саркопении. Представляет интерес взаимосвязь остеопороза, саркопении и старения у человека, лечебные и профилактические мероприятия, направленные для предотвращения этих патологических состояний.

1. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К. и др. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020;(1):11-46. https://doi.org/10.37586/2686-8636-1-2020-11-46.

2. Курмаев Д.П., Булгакова С.В., Захарова Н.О. Что первично: старческая астения или саркопения? (обзор литературы). Успехи геронтологии. 2021;34(6):848-856. https://doi.org/10.34922/AE.2021.34.6.005.

3. Greco E.A., Pietschmann P., Migliaccio S. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly. Front Endocrinol (Lausanne). 2019;10:255. https://doi.org/10.3389/fendo.2019.00255.

4. Dawson A., Dennison E. Measuring the musculoskeletal aging phenotype. Maturitas. 2016;93:13-17. https://doi.org/10.1016/j.maturitas.2016.04.014.

5. Merchant R.A., Morley J.E., Izquierdo M. Editorial: Exercise, Aging and Frailty: Guidelines for Increasing Function. J Nutr Health Aging. 2021;25(4):405-409. https://doi.org/10.1007/s12603-021-1590-x.

6. Rodrigues F., Domingos C., Monteiro D., Morouço P. A Review on Aging, Sarcopenia, Falls, and Resistance Training in Community-Dwelling Older Adults. Int J Environ Res Public Health. 2022;19(2):874. Published 2022 Jan 13. https://doi.org/10.3390/ijerph19020874.

7. Benavent-Caballer V., Rosado-Calatayud P., Segura-Ortí E., Amer-Cuenca J.J., Lisón J.F. Effects of three different low-intensity exercise interventions on physical performance, muscle CSA and activities of daily living: a randomized controlled trial. Exp Gerontol. 2014;58:159-165. https://doi.org/10.1016/j.exger.2014.08.004.

8. Наумов А.В., Ховасова Н.О., Мороз В.И. и др. Локомотивный синдром: новое представление о хрупкости в пожилом возрасте. Российский журнал гериатрической медицины. 2021;(3):372-378. https://doi.org/10.37586/2686-8636-3-2021-364-370

9. Сафонова Ю.А., Зоткин Е.Г., Торопцова Н.В. Качество жизни и синдром усталости у пожилых пациентов с саркопенией. Современная ревматология. 2021;15(6):41–47. https://doi.org/10.14412/1996-7012-2021-6-41-47.

10. Pasco J.A., Mohebbi M., Holloway K.L., Brennan-Olsen S.L., Hyde N.K., Kotowicz M.A. Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study. J Cachexia Sarcopenia Muscle. 2017;8(3):482-489. https://doi.org/10.1002/jcsm.12177

11. Yoshimura N., Muraki S., Iidaka T., et al. Prevalence and coexistence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study. J Bone Miner Metab. 2019;37(6):1058-1066. https://doi.org/10.1007/s00774-019-01012-0.

12. Онучина Ю.С., Гурьева И.В. Взаимосвязь саркопении и сахарного диабета типа 2. Эндокринология: новости, мнения, обучение. 2018;7(4):32-41. https://doi.org/10.24411/2304-9529-2018-14004

13. Курмаев Д.П., Булгакова С.В., Захарова Н.О. Биоимпедансный анализ состава тела и фазовый угол в диагностике саркопении и старческой астении (обзор литературы). Успехи геронтологии. 2022;35(2):294-301. https://doi.org/10.34922/AE.2022.35.2.014.

14. Иванникова Е.В., Дудинская Е.Н., Онучина Ю.С. Метаболизм мышечной ткани у лиц пожилого возраста. Российский журнал гериатрической медицины. 2022;(2):96-102. https://doi.org/10.37586/2686-8636-2-2022-96-102

15. Piotrowicz K., Gąsowski J., Michel J.P., Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887-2898. https://doi.org/10.1007/s40520-021-01942-8.

16. Kirwan R., McCullough D., Butler T., Perez de Heredia F., Davies I.G., Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience. 2020;42(6):1547-1578. https://doi.org/10.1007/s11357-020-00272-3.

17. Edwards M.H., Dennison E.M., Aihie Sayer A., Fielding R., Cooper C. Osteoporosis and sarcopenia in older age. Bone. 2015;80:126-130. https://doi.org/10.1016/j.bone.2015.04.016.

18. Curtis E., Litwic A., Cooper C., Dennison E. Determinants of Muscle and Bone Aging. J Cell Physiol. 2015;230(11):2618-2625. https://doi.org/10.1002/jcp.25001.

19. Clynes M.A., Gregson C.L., Bruyère O., Cooper C., Dennison E.M. Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford). 2021;60(2):529-537. https://doi.org/10.1093/rheumatology/keaa755.

20. Исаева Б.И., Алиева-Хархарова К.М. Остеосаркопения как спутник старения. Медицинский совет. 2023;17(9):130–136. https://doi.org/10.21518/ms2023-147

21. Kirk B., Zanker J., Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 2020;11(3):609-618. https://doi.org/10.1002/jcsm.12567.

22. Donini L.M., Busetto L., Bischoff S.C., et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321-335. https://doi.org/10.1159/000521241.

23. Курмаев Д.П., Булгакова С.В., Тренева Е.В. Саркопеническое ожирение — актуальная проблема современной гериатрии. Российский журнал гериатрической медицины. 2022;(4):228-235. https://doi.org/10.37586/2686-8636-4-2022-228-235

24. Бернс С.А., Шептулина А.Ф., Мамутова Э.М. и др. Саркопеническое ожирение: эпидемиология, патогенез и особенности диагностики. Кардиоваскулярная терапия и профилактика. 2023;22(6):3576. https://doi.org/10.15829/1728-8800-2023-3576

25. Цыганков Д.А., Кривошапова К.Е., Цыганкова Д.П. Ультразвуковые возможности диагностики саркопенического ожирения. Российский кардиологический журнал. 2023;28(3S):5345. https://doi.org/10.15829/1560-4071-2023-5345

26. Самойлова Ю.Г., Матвеева М.В., Хорошунова Е.А. и др. Кардиометаболические факторы риска у пациентов с сахарным диабетом 2 типа и саркопенией. Кардиоваскулярная терапия и профилактика. 2024;23(1):3655. https://doi.org/10.15829/1728-8800-2024-3655

27. Hu K., Deya Edelen E., Zhuo W., et al. Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition. Metabolites. 2023;13(10):1056. Published 2023 Oct 7. https://doi.org/10.3390/metabo13101056.

28. Dequeker J. Quantitative radiology: radiogrammetry of cortical bone. Br J Radiol. 1976;49(587):912-920. https://doi.org/10.1259/0007-1285-49-587-912.

29. Cameron J., Sorensson J. Measurement of bone mineral in vivo: an improved method. Science. 1963;142:230–232. https://doi.org/10.1126/science.142.3589.230.

30. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129. https://pubmed.ncbi.nlm.nih.gov/7941614.

31. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254-1259. https://doi.org/10.1136/bmj.312.7041.1254.

32. Kanis J.A., McCloskey E., Johansson H., Oden A., Leslie W.D., et al. FRAX(®) with and without bone mineral density. Calcif Tissue Int. 2012;90(1):1-13. https://doi.org/10.1007/s00223-011-9544-7.

33. Шарашкина Н.В., Наумов А.В., Дудинская Е.Н. и др. Консенсус экспертов: диагностика остеопороза и саркопении у пациентов пожилого и старческого возраста (сокращенная версия) Терапия. 2023;(10):7-20. https://doi.org/10.18565/therapy.2023.10.7-20.

34. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-991S. https://doi.org/10.1093/jn/127.5.990S.

35. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M,. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. https://doi.org/10.1093/ageing/afq034.

36. Самойлова Ю.Г., Матвеева М.В., Хорошунова Е.А. и др. Композиционный состав тела при саркопении у лиц среднего возраста. Терапевтический архив. 2022;94(10):1149-1154. https://doi.org/10.26442/00403660.2022.10.201878

37. Хорошунова Е.А., Самойлова Ю.Г., Матвеева М.В. и др. Оценка методов диагностики саркопении у лиц с нарушением углеводного обмена на современном этапе. Профилактическая медицина. 2022;25(10):116-121. https://doi.org/10.17116/profmed202225101116.

38. Самойлова Ю.Г., Матвеева М.В., Хорошунова Е.А. и др. Предиктивная диагностика факторов риска развития саркопении у пожилых пациентов с сахарным диабетом 2 типа. Архив внутренней медицины. 2024;14(1):52-62. https://doi.org/10.20514/2226-6704-2024-14-1-52-62

39. Сафонова Ю.А., Торопцова Н.В. Частота и факторы риска саркопении у людей старших возрастных групп. Клиницист. 2022;16(2):40-47. https://doi.org/10.17650/1818-8338-2022-16-2-K661

40. Шеберова Е.В., Силантьева Н.К., Агабабян Т.А. и др. Роль компьютерной томографии в диагностике саркопении. Сибирский онкологический журнал. 2023;22(3):125–133. https://doi.org/10.21294/1814-4861-2023-22-3-125-133

41. Hirschfeld H.P., Kinsella R., Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28(10):27812790. https://doi.org/10.1007/s00198-017-4151-8.

42. Huo Y.R., Suriyaarachchi P., Gomez F., et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015;16(4):290-295. https://doi.org/10.1016/j.jamda.2014.10.018.

43. Wang Y.J., Wang Y., Zhan J.K., et al. Sarco-Osteoporosis: Prevalence and Association with Frailty in Chinese Community-Dwelling Older Adults. Int J Endocrinol. 2015;2015:482940. https://doi.org/10.1155/2015/482940.

44. Huang T., Li C., Chen F., et al. Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis. BMC Geriatr. 2023;23(1):369. Published 2023 Jun 15. https://doi.org/10.1186/s12877-023-04085-9.

45. Locquet M., Beaudart C., Bruyère O., Kanis J.A., Delandsheere L., Reginster J.Y. Bone health assessment in older people with or without muscle health impairment. Osteoporos Int. 2018;29(5):10571067. https://doi.org/10.1007/s00198-018-4384-1.

46. Di Monaco M., Vallero F., Di Monaco R., Tappero R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr. 2011;52(1):71-74. https://doi.org/10.1016/j.archger.2010.02.002.

47. Yoo J.I., Kim H., Ha Y.C., Kwon H.B., Koo K.H. Osteosarcopenia in Patients with Hip Fracture Is Related with High Mortality. J Korean Med Sci. 2018;33(4):e27. Published 2018 Jan 22. https://doi.org/10.3346/jkms.2018.33.e27.

48. Schröder G., Flachsmeyer D., Bende A, Andresen J.R., Andresen R., Schober H.C. Einfluss von Osteoporose auf physische Leistungsparameter von Personen im mittleren und höheren Lebensalter — eine Querschnittstudie [Impact of osteoporosis on physical performance parameters of middle-aged and elderly individuals-a cross-sectional study]. Orthopadie (Heidelb). 2023;52(1):54-64. https://doi.org/10.1007/s00132-022-04329-3.

49. Petermann-Rocha F., Ferguson L.D., Gray S.R., et al. Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants. J Cachexia Sarcopenia Muscle. 2021;12(5):1179-1188. https://doi.org/10.1002/jcsm.12757.

50. Addison O., Marcus R.L., Lastayo P.C., Ryan A.S. Intermuscular fat: a review of the consequences and causes. Int J Endocrinol. 2014;2014:309570. https://doi.org/10.1155/2014/309570.

51. De Laet C., Kanis J.A., Odén A., et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330-1338. https://doi.org/10.1007/s00198-005-1863-y.

52. Reid I.R. Fat and bone. Arch Biochem Biophys. 2010;503(1):20-27. https://doi.org/10.1016/j.abb.2010.06.027.

53. Compston J. Obesity and fractures in postmenopausal women. Curr Opin Rheumatol. 2015;27(4):414-419. https://doi.org/10.1097/BOR.0000000000000182.

54. Kawao N., Kaji H. Interactions between muscle tissues and bone metabolism. J Cell Biochem. 2015;116(5):687-695. https://doi.org/10.1002/jcb.25040.

55. Binder E.F., Yarasheski K.E, Steger-May K., et al. Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. J Gerontol A Biol Sci Med Sci. 2005;60(11):1425-1431. https://doi.org/10.1093/gerona/60.11.1425.

56. Kemmler W., von Stengel S., Engelke K., Häberle L., Mayhew J.L., Kalender W.A. Exercise, body composition, and functional ability: a randomized controlled trial. Am J Prev Med. 2010;38(3):279-287. https://doi.org/10.1016/j.amepre.2009.10.042.

57. Prieto-Alhambra D., Premaor M.O., Fina Avilés F., et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res. 2012;27(2):294-300. https://doi.org/10.1002/jbmr.1466.

58. Avin K.G., Bloomfield S.A., Gross T.S., Warden S.J. Biomechanical aspects of the muscle-bone interaction. Curr Osteoporos Rep. 2015;13(1):1-8. https://doi.org/10.1007/s11914-014-0244-x.

59. Karasik D., Kiel D.P. Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res. 2008;23(6):788-802. https://doi.org/10.1359/jbmr.080218.

60. Frost H.M. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275(2):1081-1101. https://doi.org/10.1002/ar.a.10119.

61. Brotto M., Bonewald L. Bone and muscle: Interactions beyond mechanical. Bone. 2015;80:109-114. https://doi.org/10.1016/j.bone.2015.02.010.

62. Utvåg S.E., Grundnes O., Rindal D.B., Reikerås O. Influence of extensive muscle injury on fracture healing in rat tibia. J Orthop Trauma. 2003;17(6):430-435. https://doi.org/10.1097/00005131-200307000-00007.

63. Shen H., Grimston S., Civitelli R., Thomopoulos S. Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res. 2015;30(4):596-605. https://doi.org/10.1002/jbmr.2389.

64. Dalle Carbonare L., Minoia A., Zouari S., et al. Crosstalk between Bone and Muscles during Physical Activity. Cells. 2023;12(16):2088. Published 2023 Aug 18. https://doi.org/10.3390/cells12162088.

65. Tiidus P.M. Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies. Eurasian J Med. 2011;43(2):109114. https://doi.org/10.5152/eajm.2011.24.

66. Anton S.D., Woods A.J., Ashizawa T., et al. Successful aging: Advancing the science of physical independence in older adults. Ageing Res Rev. 2015;24(Pt B):304-327. https://doi.org/10.1016/j.arr.2015.09.005.

67. Sullivan S.D., Sarrel P.M., Nelson L.M. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):15881599. https://doi.org/10.1016/j.fertnstert.2016.09.046.

68. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889896. https://doi.org/10.1046/j.1532-5415.2002.50216.x.

69. Hyde Z., Flicker L., Almeida O.P., et al. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab. 2010;95(7):3165-3172. https://doi.org/10.1210/jc.2009-2754.

70. Vandenput L., Mellström D., Laughlin G.A, et al. Low Testosterone, but Not Estradiol, Is Associated With Incident Falls in Older Men: The International MrOS Study. J Bone Miner Res. 2017;32(6):1174-1181. https://doi.org/10.1002/jbmr.3088.

71. Булгакова С.В., Курмаев Д.П., Силютина М.В. и др. Вклад эндокринной системы в развитие остеопороза у лиц пожилого и старческого возраста (обзор). Научные результаты биомедицинских исследований. 2021;7(3):308-321. https://doi.org/10.18413/2658-6533-2021-7-3-0-9.

72. Tritos N.A., Biller B.M. Growth hormone and bone. Curr Opin Endocrinol Diabetes Obes. 2009;16(6):415-422. https://doi.org/10.1097/MED.0b013e3283319e6d.

73. Urban R.J. Growth hormone and testosterone: anabolic effects on muscle. Horm Res Paediatr. 2011;76 Suppl 1:81-83. https://doi.org/10.1159/000329184.

74. Girgis C.M., Mokbel N., Digirolamo D.J. Therapies for musculoskeletal disease: can we treat two birds with one stone? Curr Osteoporos Rep. 2014;12(2):142-153. https://doi.org/10.1007/s11914-014-0204-5.

75. Cederholm T., Cruz-Jentoft A.J., Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med. 2013;49(1):111-117. https://www.minervamedica.it/en/journals/europa-medicophysica/ article.php?cod=R33Y2013N01A0111.

76. Moretti A., Iolascon G. Sclerostin: clinical insights in musclebone crosstalk. J Int Med Res. 2023;51(8):3000605231193293. https://doi.org/10.1177/03000605231193293.

77. Suo J., Zou S., Wang J., et al. The RNA-binding protein Musashi2 governs osteoblast-adipocyte lineage commitment by suppressing PPARγ signaling. Bone Res. 2022;10(1):31. Published 2022 Mar 17. https://doi.org/10.1038/s41413-022-00202-3.

78. Paintin J., Cooper C., Dennison E. Osteosarcopenia. Br J Hosp Med (Lond). 2018;79(5):253-258. https://doi.org/10.12968/hmed.2018.79.5.253.

79. Marzetti E., Calvani R., Bernabei R., Leeuwenburgh C. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty — a mini-review. Gerontology. 2012;58(2):99-106. https://doi.org/10.1159/000330064.

80. Zanker J., Duque G. Osteoporosis in Older Persons: Old and New Players. J Am Geriatr Soc. 2019;67(4):831-840. https://doi.org/10.1111/jgs.15716.

81. Cosman F., de Beur S.J., LeBoff M.S., et al. Clinician's Guide to Prevention and Treatment of Osteoporosis [published correction appears in Osteoporos Int. 2015 Jul;26(7):2045-7]. Osteoporos Int. 2014;25(10):2359-2381. https://doi.org/10.1007/s00198-014-2794-2.

82. Bonnet N., Bourgoin L., Biver E., Douni E., Ferrari S. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass [published correction appears in J Clin Invest. 2020 Jun 1;130(6):3329] [published correction appears in J Clin Invest. 2023 Feb 15;133(4):]. J Clin Invest. 2019;129(8):32143223. Published 2019 May 23. https://doi.org/10.1172/JCI125915.

83. Phu S., Bani Hassan E., Vogrin S., Kirk B., Duque G. Effect of Denosumab on Falls, Muscle Strength, and Function in Community-Dwelling Older Adults. J Am Geriatr Soc. 2019;67(12):2660-2661. https://doi.org/10.1111/jgs.16165.

84. Howe T.E., Shea B., Dawson L.J., et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011;(7):CD000333. Published 2011 Jul 6. https://doi.org/10.1002/14651858.CD000333.pub2.

85. Kortebein P., Ferrando A., Lombeida J., Wolfe R., Evans W.J. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1772-1774. https://doi.org/10.1001/jama.297.16.1772-b.

86. Sutor T.W., Kura J., Mattingly A.J., Otzel D.M., Yarrow J.F. The Effects of Exercise and Activity-Based Physical Therapy on Bone after Spinal Cord Injury. Int J Mol Sci. 2022;23(2):608. Published 2022 Jan 6. https://doi.org/10.3390/ijms23020608.

87. Knauer K., Chaudry O., Uder M., et al. Effects of High-Intensity Resistance Training on Visceral Adipose Tissue and Abdominal Aortic Calcifications in Older Men with Osteosarcopenia — Results from the FrOST Study. Clin Interv Aging. 2023;18:71-80. Published 2023 Jan 19. https://doi.org/10.2147/CIA.S388026.

88. Dent E., Daly R.M., Hoogendijk E.O., Scott D. Exercise to Prevent and Manage Frailty and Fragility Fractures. Curr Osteoporos Rep. 2023;21(2):205-215. https://doi.org/10.1007/s11914-023-00777-8.

89. Briggs R.A., Houck J.R., Drummond M.J., Fritz JM., LaStayo P.C., Marcus R.L. Muscle Quality Improves with Extended High-Intensity Resistance Training after Hip Fracture. J Frailty Aging. 2018;7(1):51-56. https://doi.org/10.14283/jfa.2017.31.

90. Shen Y., Shi Q., Nong K., et al. Exercise for sarcopenia in older people: A systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1199-1211. https://doi.org/10.1002/jcsm.13225.

91. Angulo J., El Assar M., Álvarez-Bustos A., Rodríguez-Mañas L. Physical activity and exercise: Strategies to manage frailty. Redox Biol. 2020;35:101513. https://doi.org/10.1016/j.redox.2020.101513.

92. Goodpaster B.H., Park S.W., Harris T.B., et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059-1064. https://doi.org/10.1093/gerona/61.10.1059.

93. Kaiser M., Bandinelli S., Lunenfeld B. Frailty and the role of nutrition in older people. A review of the current literature. Acta Biomed. 2010;81 Suppl 1:37-45. https://pubmed.ncbi.nlm.nih.gov/20518190.

94. Robinson S.M., Reginster J.Y., Rizzoli R., et al. Does nutrition play a role in the prevention and management of sarcopenia?. Clin Nutr. 2018;37(4):1121-1132. https://doi.org/10.1016/j.clnu.2017.08.016.

95. Hernández Morante J.J., Gómez Martínez C., Morillas-Ruiz J.M. Dietary Factors Associated with Frailty in Old Adults: A Review of Nutritional Interventions to Prevent Frailty Development. Nutrients. 2019;11(1):102. Published 2019 Jan 5. https://doi.org/10.3390/nu11010102.

96. Veronese N., Stubbs B., Punzi L., et al. Effect of nutritional supplementations on physical performance and muscle strength parameters in older people: A systematic review and metaanalysis. Ageing Res Rev. 2019;51:48-54. https://doi.org/10.1016/j.arr.2019.02.005.

97. Cereda E., Pisati R., Rondanelli M., Caccialanza R. Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia. Nutrients. 2022;14(7):1524. Published 2022 Apr 6. https://doi.org/10.3390/nu14071524.

98. Tang B.M., Eslick G.D., Nowson C., Smith C., Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007 Aug 25;370(9588):657-66. https://doi.org/10.1016/S0140-6736(07)61342-7.

99. Bischoff-Ferrari H.A., Dawson-Hughes B., Baron J.A., et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007;86(6):1780-1790. https://doi.org/10.1093/ajcn/86.5.1780

100. Bolland M.J., Leung W., Tai V., et al. Calcium intake and risk of fracture: systematic review. BMJ. 2015;351:h4580. Published 2015 Sep 29. https://doi.org/10.1136/bmj.h4580.

101. Beaudart C., Buckinx F., Rabenda V., et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99(11):4336-4345. https://doi.org/10.1210/jc.2014-1742.

102. Shams-White M.M., Chung M., Du M., et al. Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. Am J Clin Nutr. 2017;105(6):1528-1543. https://doi.org/10.3945/ajcn.116.145110.

103. Cordingley D.M., Cornish S.M., Candow D.G. Anti-Inflammatory and Anti-Catabolic Effects of Creatine Supplementation: A Brief Review. Nutrients. 2022;14(3):544. Published 2022 Jan 27. https://doi.org/10.3390/nu14030544.